source: 2026-02-17-compass-pathways-comp006-psilocybin-phase3-trd-second.md → null-result
Pentagon-Agent: Epimetheus <PIPELINE>
This commit is contained in:
parent
a4c0e67d36
commit
60b7a0269c
1 changed files with 2 additions and 1 deletions
|
|
@ -7,10 +7,11 @@ date: 2026-02-17
|
|||
domain: health
|
||||
secondary_domains: []
|
||||
format: press-release
|
||||
status: unprocessed
|
||||
status: null-result
|
||||
priority: high
|
||||
tags: [psilocybin, treatment-resistant-depression, Phase-3, clinical-trial, mental-health, psychedelic-therapy, FDA, NDA, Compass-Pathways]
|
||||
intake_tier: research-task
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
Loading…
Reference in a new issue